Skip to content

Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis

Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05838144
Enrollment
20
Registered
2023-05-01
Start date
2023-08-01
Completion date
2023-10-20
Last updated
2023-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis

Brief summary

1. Acapella group. Will use Acapella device for 3 times per day for 15 minutes for 7 days beside medications and routine chest physical therapy program . 2. Only routine physical therapy program group ( control group). Will only take medications and routine chest physical therapy program.

Detailed description

1. Acapella group.Will use Acapella device for 3 times per day for 15 minutes for 7 days beside medications and routine chest physical therapy program. 2. Only routine physical therapy program group( control group). Will only take medications and routine chest physical therapy program Spirometer measures such as forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1) will be measured for every patient before and after the end of 7 days.

Interventions

Group A. Will use Acapella device.

OTHEROnly routine chest physical therapy program

Group B. Will take medications and perform routine chest physical therapy program.

Sponsors

South Valley University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

1. bronchiectasis patients. 2. Age range between 40 to 55 years old of both gender. 3. Cooperative patients.

Exclusion criteria

1. Patients with severe cardiac disorders. 2. Un controlled hypertensive patients. 3. Un controlled diabetic patients.

Design outcomes

Primary

MeasureTime frameDescription
Spirometry measures7 daysFVC, FEV1

Countries

Egypt

Contacts

Primary ContactShymaa Y Abo zaid
shaymaayoussef397@gmail.com01010941685

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026